NASDAQ Composite ended the session with FibroGen jumping 7.13% to $20.35 on Tuesday while nASDAQ Composite fell 0.92% to $13,786.27.
FibroGen today’s close was $20.35, 181.13% under its 52-week high of $57.21.
The company’s growth estimates for the ongoing quarter and the next is 2.2% and 62.1%, respectively.
Year-on-year quarterly revenue growth grew by 715.1%, now sitting on 176.32M for the twelve trailing months.
FibroGen’s last day, last week, and last month’s current volatility was 4.79%, 2.28%, and 6.50%, respectively.
FibroGen‘s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 4.55% (day), 5.13% (last week), and 6.30% (last month), respectively.
FibroGen’s Stock Yearly Top and Bottom Value
FibroGen’s stock is valued at $20.35 at 17:10 EST, way below its 52-week high of $57.21 and higher than its 52-week low of $18.77.
FibroGen’s Moving Average
FibroGen’s worth is way under its 50-day moving average of $39.14 and way under its 200-day moving average of $42.31.
More news about FibroGen.